Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn

Published on September 21, 2026

Telix will pay $1.65 billion in cash upfront for 100 percent of ITM's shares, plus up to $700 million in contingency payments.

The post Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn appeared first on PE Hub.

Continue reading on website
Other news

Risk of ‘two-speed response’ on nature reporting, warns TNFD

September 21, 2026
Investors want faster movement on mandatory nature-related reporting than regulators, says CEO Tony Goldner.

HealthEdge-backed Veridian closes acquisition of ScarScience brand from Mitchell-Vance Laboratories

September 21, 2026
The deal strengthens Veridian's position in scar and wound care and extends its reach in plastic surgery, dermatology, and physical therapy.The post HealthEdge-backed Veridian closes acquisition of ScarScience brand from Mitchell-Vance Laboratories appeared first on PE Hub.